Steven Cohen's RPRX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 534,306 shares of Royalty Pharma plc (RPRX) worth $20.65 M, representing 0.02% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in RPRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 1.56 M shares. Largest reduction occurred in Q2 2022, reducing 1.89 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Royalty Pharma plc (RPRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Royalty Pharma plc (RPRX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +534,306 | New Buy | 534,306 | $38.64 |
| Q1 2025 | -249,003 | Sold Out | 0 | $0.00 |
| Q4 2024 | -277,630 | Reduce 52.72% | 249,003 | $25.51 |
| Q3 2024 | +526,633 | New Buy | 526,633 | $28.29 |
| Q2 2024 | -521,200 | Sold Out | 0 | $0.00 |
| Q1 2024 | -647,600 | Reduce 55.41% | 521,200 | $30.37 |
| Q4 2023 | +440,600 | Add 60.51% | 1.17 M | $28.09 |
| Q3 2023 | +198,000 | Add 37.34% | 728,200 | $27.14 |
| Q2 2023 | -88,600 | Reduce 14.32% | 530,200 | $30.74 |
| Q1 2023 | +618,800 | New Buy | 618,800 | $36.03 |
| Q2 2022 | -1.89 M | Sold Out | 0 | $0.00 |
| Q1 2022 | +1.56 M | Add 463.20% | 1.89 M | $38.96 |
| Q4 2021 | +277,000 | Add 468.70% | 336,100 | $39.85 |
| Q3 2021 | +59,100 | New Buy | 59,100 | $36.14 |
Steven Cohen's Royalty Pharma plc Investment FAQs
Steven Cohen first purchased Royalty Pharma plc (RPRX) in Q3 2021, acquiring 59,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Royalty Pharma plc (RPRX) for 14 quarters since Q3 2021.
Steven Cohen's largest addition to Royalty Pharma plc (RPRX) was in Q1 2022, adding 1,892,900 shares worth $73.75 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 534,306 shares of Royalty Pharma plc (RPRX), valued at approximately $20.65 M.
As of the Q4 2025 filing, Royalty Pharma plc (RPRX) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Royalty Pharma plc (RPRX) was 1,892,900 shares, as reported at the end of Q1 2022.